UNIVERSAL TECHNICAL INSTITUT (UTI) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:UTI - US9139151040 - Common Stock
24.65 USD
-0.34 (-1.36%)
We assign a fundamental rating of 5 out of 10 to UTI. UTI was compared to 76 industry peers in the Diversified Consumer Services industry. While UTI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. UTI has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
UTI had positive earnings in the past year.
In the past year UTI had a positive cash flow from operations.
Of the past 5 years UTI 4 years were profitable.
UTI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 8.52%, UTI is in the better half of the industry, outperforming 78.95% of the companies in the same industry.
Looking at the Return On Equity, with a value of 20.57%, UTI belongs to the top of the industry, outperforming 86.84% of the companies in the same industry.
The Return On Invested Capital of UTI (10.86%) is better than 84.21% of its industry peers.
UTI had an Average Return On Invested Capital over the past 3 years of 5.11%. This is below the industry average of 8.97%.
The last Return On Invested Capital (10.86%) for UTI is above the 3 year average (5.11%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.52% | ||
| ROE | 20.57% | ||
| ROIC | 10.86% |
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
1.3 Margins
UTI has a better Profit Margin (7.79%) than 68.42% of its industry peers.
In the last couple of years the Profit Margin of UTI has grown nicely.
UTI has a better Operating Margin (10.44%) than 67.11% of its industry peers.
In the last couple of years the Operating Margin of UTI has grown nicely.
UTI has a Gross Margin (49.65%) which is comparable to the rest of the industry.
UTI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.44% | ||
| PM (TTM) | 7.79% | ||
| GM | 49.65% |
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
2. Health
2.1 Basic Checks
UTI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
There is no outstanding debt for UTI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
UTI has an Altman-Z score of 3.51. This indicates that UTI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.51, UTI belongs to the top of the industry, outperforming 80.26% of the companies in the same industry.
UTI has a debt to FCF ratio of 0.99. This is a very positive value and a sign of high solvency as it would only need 0.99 years to pay back of all of its debts.
The Debt to FCF ratio of UTI (0.99) is better than 85.53% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that UTI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.23, UTI is in line with its industry, outperforming 55.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.99 | ||
| Altman-Z | 3.51 |
ROIC/WACC1.29
WACC8.42%
2.3 Liquidity
UTI has a Current Ratio of 1.00. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.00, UTI is in line with its industry, outperforming 42.11% of the companies in the same industry.
UTI has a Quick Ratio of 1.00. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of UTI (1.00) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 54.05% over the past year.
The Earnings Per Share has been growing slightly by 3.11% on average over the past years.
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.28%
3.2 Future
The Earnings Per Share is expected to decrease by -11.46% on average over the next years. This is quite bad
Based on estimates for the next years, UTI will show a quite strong growth in Revenue. The Revenue will grow by 9.04% on average per year.
EPS Next Y-29.91%
EPS Next 2Y-11.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.06%
Revenue Next 2Y9.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 21.62, the valuation of UTI can be described as rather expensive.
UTI's Price/Earnings ratio is a bit cheaper when compared to the industry. UTI is cheaper than 60.53% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.76, UTI is valued at the same level.
A Price/Forward Earnings ratio of 30.85 indicates a quite expensive valuation of UTI.
UTI's Price/Forward Earnings is on the same level as the industry average.
UTI's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.96.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.62 | ||
| Fwd PE | 30.85 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UTI is valued a bit cheaper than the industry average as 65.79% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, UTI is valued a bit cheaper than the industry average as 69.74% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.95 | ||
| EV/EBITDA | 10.39 |
4.3 Compensation for Growth
The decent profitability rating of UTI may justify a higher PE ratio.
A cheap valuation may be justified as UTI's earnings are expected to decrease with -11.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.46%
EPS Next 3YN/A
5. Dividend
5.1 Amount
UTI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:UTI (12/12/2025, 10:34:46 AM)
24.65
-0.34 (-1.36%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners94.95%
Inst Owner Change-1.21%
Ins Owners2.24%
Ins Owner Change0.18%
Market Cap1.34B
Revenue(TTM)N/A
Net Income(TTM)63.10M
Analysts81.82
Price Target38.18 (54.89%)
Short Float %3.85%
Short Ratio2.77
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.03
Dividend Growth(5Y)-34.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.27%
Min EPS beat(2)69.26%
Max EPS beat(2)73.27%
EPS beat(4)4
Avg EPS beat(4)69.47%
Min EPS beat(4)12.21%
Max EPS beat(4)123.12%
EPS beat(8)7
Avg EPS beat(8)80.23%
EPS beat(12)10
Avg EPS beat(12)129.78%
EPS beat(16)14
Avg EPS beat(16)215.22%
Revenue beat(2)2
Avg Revenue beat(2)2.83%
Min Revenue beat(2)1.15%
Max Revenue beat(2)4.51%
Revenue beat(4)4
Avg Revenue beat(4)2.54%
Min Revenue beat(4)1.15%
Max Revenue beat(4)4.51%
Revenue beat(8)8
Avg Revenue beat(8)2.39%
Revenue beat(12)11
Avg Revenue beat(12)2.98%
Revenue beat(16)15
Avg Revenue beat(16)3.43%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.46%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.62 | ||
| Fwd PE | 30.85 | ||
| P/S | 1.66 | ||
| P/FCF | 17.95 | ||
| P/OCF | 12.45 | ||
| P/B | 4.37 | ||
| P/tB | 5.15 | ||
| EV/EBITDA | 10.39 |
EPS(TTM)1.14
EY4.62%
EPS(NY)0.8
Fwd EY3.24%
FCF(TTM)1.37
FCFY5.57%
OCF(TTM)1.98
OCFY8.03%
SpS14.87
BVpS5.64
TBVpS4.79
PEG (NY)N/A
PEG (5Y)N/A
Graham Number12.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.52% | ||
| ROE | 20.57% | ||
| ROCE | 15.21% | ||
| ROIC | 10.86% | ||
| ROICexc | 13.78% | ||
| ROICexgc | 15.4% | ||
| OM | 10.44% | ||
| PM (TTM) | 7.79% | ||
| GM | 49.65% | ||
| FCFM | 9.23% |
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
ROICexc(3y)7.05%
ROICexc(5y)N/A
ROICexgc(3y)7.97%
ROICexgc(5y)N/A
ROCE(3y)7.15%
ROCE(5y)N/A
ROICexgc growth 3Y41.64%
ROICexgc growth 5YN/A
ROICexc growth 3Y37.09%
ROICexc growth 5YN/A
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.99 | ||
| Debt/EBITDA | 0.58 | ||
| Cap/Depr | 87.82% | ||
| Cap/Sales | 4.08% | ||
| Interest Coverage | 11.6 | ||
| Cash Conversion | 88.25% | ||
| Profit Quality | 118.43% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.51 |
F-Score6
WACC8.42%
ROIC/WACC1.29
Cap/Depr(3y)259.47%
Cap/Depr(5y)259.17%
Cap/Sales(3y)10.54%
Cap/Sales(5y)10.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-29.91%
EPS Next 2Y-11.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.28%
Revenue Next Year9.06%
Revenue Next 2Y9.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y85.69%
EBIT growth 3Y58.11%
EBIT growth 5YN/A
EBIT Next Year114.2%
EBIT Next 3Y28.12%
EBIT Next 5YN/A
FCF growth 1Y395.38%
FCF growth 3YN/A
FCF growth 5Y32.12%
OCF growth 1Y222.73%
OCF growth 3Y15.89%
OCF growth 5Y31.61%
UNIVERSAL TECHNICAL INSTITUT / UTI FAQ
What is the fundamental rating for UTI stock?
ChartMill assigns a fundamental rating of 5 / 10 to UTI.
Can you provide the valuation status for UNIVERSAL TECHNICAL INSTITUT?
ChartMill assigns a valuation rating of 3 / 10 to UNIVERSAL TECHNICAL INSTITUT (UTI). This can be considered as Overvalued.
Can you provide the profitability details for UNIVERSAL TECHNICAL INSTITUT?
UNIVERSAL TECHNICAL INSTITUT (UTI) has a profitability rating of 7 / 10.
What are the PE and PB ratios of UNIVERSAL TECHNICAL INSTITUT (UTI) stock?
The Price/Earnings (PE) ratio for UNIVERSAL TECHNICAL INSTITUT (UTI) is 21.62 and the Price/Book (PB) ratio is 4.37.
Can you provide the expected EPS growth for UTI stock?
The Earnings per Share (EPS) of UNIVERSAL TECHNICAL INSTITUT (UTI) is expected to decline by -29.91% in the next year.